Categories
All News

Hematology Tests Market Report- In-depth Analysis with Strong Application Scope | Silver Lake Research Corporation, T2 Biosystems Inc

ReportsnReports added Hematology Tests Market Research Report created by Report Consultant, which offers detailed insights, revenue details, and other information regarding the global market, and the various trends, drivers, restraints, opportunities, and market till 2028. Hematology Tests Market Report offers detailed information regarding the leading key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions and mergers, and market footprint. Hematology Tests Market also provides a comparative analysis of the market dynamics pre and post Covid19 outbreak.

Request for FREE PDF Sample Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=3926468

Top Company Profile Analysis in this Report

Aptitude Medical Systems Inc

ARUP Laboratories

BioMedomics Inc

Biosurfit, SA

DxDiscovery Inc

Dynasil Corporation of America

ET Healthcare Inc

genedrive plc

Group K Diagnostics

hemCheck Sweden AB

Ohio State University

Optolane Technologies Inc

PortaScience Inc

Retham Technologies LLC

Sanguina LLC

Siemens Healthcare Diagnostics Inc

Silver Lake Research Corporation

T2 Biosystems Inc

University of Melbourne

VitaMe Technologies Inc

Hematology Tests Market Report provides comprehensive information about the Hematology Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Hematology tests include various blood tests that help diagnose and monitor various conditions. It includes the sub-segments Complete Blood Count (CBC) Tests, Hemoglobin Laboratory Tests, Hemoglobin Point of Care (POC) Tests, Hematocrit Point of Care (POC) Tests, Hemoglobin & Hematocrit POC Tests, Erythrocytes Point of Care (POC) Tests, White Blood Count Point of Care (POC) Tests and Platelets Point of Care (POC) Tests.

Scope of this Report- 
– Extensive coverage of the Hematology Tests under development
– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
– The report reviews the major players involved in the development of Hematology Tests and list all their pipeline projects
– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
– The report provides key clinical trial data of ongoing trials specific to pipeline products
– Recent developments in the segment / industry

Reasons to Buy this Report-
The report enables you to –
– Formulate significant competitor information, analysis, and insights to improve R&D strategies
– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
– Identify and understand important and diverse types of Hematology Tests under development
– Develop market-entry and market expansion strategies
– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
– In-depth analysis of the product’s current stage of development, territory and estimated launch date

Single User License: US $ 4000
Get FLAT 25% Discount on this Report @ https://www.reportsnreports.com/purchase.aspx?name=3926468

Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Hematology Tests Overview
3 Products under Development
3.1 Hematology Tests – Pipeline Products by Stage of Development
3.2 Hematology Tests – Pipeline Products by Segment
3.3 Hematology Tests – Pipeline Products by Territory
3.4 Hematology Tests – Pipeline Products by Regulatory Path
3.5 Hematology Tests – Pipeline Products by Estimated Approval Date
4 Hematology Tests – Pipeline Products under Development by Companies
4.1 Hematology Tests Companies – Pipeline Products by Stage of Development
4.2 Hematology Tests – Pipeline Products by Stage of Development
5 Hematology Tests Companies and Product Overview
5.1 Aptitude Medical Systems Inc Company Overview
5.1.1 Aptitude Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
5.2 ARUP Laboratories Company Overview
5.2.1 ARUP Laboratories Pipeline Products & Ongoing Clinical Trials Overview
5.3 BioMedomics Inc Company Overview
5.3.1 BioMedomics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.4 Biosurfit, SA Company Overview
5.4.1 Biosurfit, SA Pipeline Products & Ongoing Clinical Trials Overview
5.5 DxDiscovery Inc Company Overview
5.5.1 DxDiscovery Inc Pipeline Products & Ongoing Clinical Trials Overview
5.6 Dynasil Corporation of America Company Overview
5.6.1 Dynasil Corporation of America Pipeline Products & Ongoing Clinical Trials Overview
5.7 ET Healthcare Inc Company Overview
5.7.1 ET Healthcare Inc Pipeline Products & Ongoing Clinical Trials Overview
5.8 genedrive plc Company Overview
5.8.1 genedrive plc Pipeline Products & Ongoing Clinical Trials Overview
5.9 Group K Diagnostics Company Overview
5.9.1 Group K Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
5.10 hemCheck Sweden AB Company Overview
5.10.1 hemCheck Sweden AB Pipeline Products & Ongoing Clinical Trials Overview
5.11 Ohio State University Company Overview
5.11.1 Ohio State University Pipeline Products & Ongoing Clinical Trials Overview
5.12 Optolane Technologies Inc Company Overview
5.12.1 Optolane Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
5.13 PortaScience Inc Company Overview
5.13.1 PortaScience Inc Pipeline Products & Ongoing Clinical Trials Overview
5.14 Retham Technologies LLC Company Overview
5.14.1 Retham Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
5.15 Sanguina LLC Company Overview
5.15.1 Sanguina LLC Pipeline Products & Ongoing Clinical Trials Overview
5.16 Siemens Healthcare Diagnostics Inc Company Overview
5.16.1 Siemens Healthcare Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.17 Silver Lake Research Corporation Company Overview
5.17.1 Silver Lake Research Corporation Pipeline Products & Ongoing Clinical Trials Overview
5.18 T2 Biosystems Inc Company Overview
5.18.1 T2 Biosystems Inc Pipeline Products & Ongoing Clinical Trials Overview
5.19 University of Melbourne Company Overview
5.19.1 University of Melbourne Pipeline Products & Ongoing Clinical Trials Overview
5.20 VitaMe Technologies Inc Company Overview
5.20.1 VitaMe Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
6 Hematology Tests- Recent Developments
6.1 Jun 17, 2020: Sysmex launches flow cytometer XF-1600 in North America
6.2 Jun 09, 2020: Siemens and Exyte join forces to deliver integrated solutions for fast-track construction of smart biotech facilities
6.3 May 02, 2020: Halo provides operational update
6.4 Feb 20, 2020: FDA files ARUP Laboratories’ AAV5 CDx for hemophilia A gene therapy treatment
6.5 Feb 20, 2020: BioMarin’s Biologics license application for valoctocogene roxaparvovec accepted for priority review by FDA with review action date of August 21, 2020
6.6 Feb 19, 2020: Biohit Group financial statement release 2019
6.7 Feb 13, 2020: Bio-Rad reports fourth-quarter and full-year 2019 financial results
6.8 Feb 12, 2020: Halo announces promotion of Katie Field to President of Halo and provides Bophelo Bioscience update
6.9 Feb 12, 2020: Quidel reports fourth quarter and full year 2019 financial results
6.10 Feb 07, 2020: User survey at Capio S:t Göran’s hospital show 100% support from participating staff for Hemcheck’s product concept
6.11 Feb 04, 2020: T2 Biosystems announces participation at Clinical Conferences in February
6.12 Feb 04, 2020: Bio-Rad brings FCS express flow cytometry analysis software to ZE5 cell analyzer users
6.13 Feb 03, 2020: Siemens Healthineers starts new fiscal year with strong growth – outlook confirmed
6.14 Jan 15, 2020: Accellix announces the appointment of Nir Nimrodi as chairman and chief executive officer
6.15 Jan 11, 2020: Study completed at Capio S:t Goran’s hospital showing significantly lower frequency of hemolysed blood samples at the emergency care unit when using Hemcheck’s product concept
6.16 Jan 09, 2020: Quidel announces preliminary revenue for fourth quarter 2019
6.17 Jan 06, 2020: Bio-Rad appoints Dara Grantham Wright Executive Vice President and Clinical Diagnostics Group President
6.18 Dec 23, 2019: The International Trade Commission issues final decision affirming 10X Genomics infringement of three of Bio-Rad’s Patents
6.19 Dec 13, 2019: Bio-Rad makes progress recovering from recent ransomware attack
6.20 Dec 11, 2019: Medica 2019 World Forum of Medicine
6.21 Dec 10, 2019: Siemens Healthineers gives details on second phase of Strategy 2025 and on the further development of its businesses
6.22 Dec 05, 2019: Akers Biosciences continues strategic review; explores leveraging its 30-years of laboratory operations to enter into the hemp and minor cannabinoid processing industry
6.23 Dec 03, 2019: Consort Medical: Interim results of 2019
7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer

https://jumbonews.co.uk/